2011
DOI: 10.1212/wnl.0b013e318233b1f9
|View full text |Cite
|
Sign up to set email alerts
|

Transcobalamin 2 variant associated with poststroke homocysteine modifies recurrent stroke risk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
30
0
1

Year Published

2011
2011
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(31 citation statements)
references
References 40 publications
0
30
0
1
Order By: Relevance
“…Similarly, several large-scale clinical trials (e.g. LOOK AHEAD, DASH, and VISP) have also identified genetic factors which contribute to determining responsiveness to dietary interventions (Hsu et al, 2011; McCaffery et al, 2012; Svetkey et al, 2011). Accordingly, though extensive research remains to be conducted in this area, genetic profiling may at some point aid in the prescription of both pharmaceutical and lifestyle-based interventions for the treatment of hypertension, even in late-life.…”
Section: Future Directions – Potential Points Of Interventionmentioning
confidence: 99%
“…Similarly, several large-scale clinical trials (e.g. LOOK AHEAD, DASH, and VISP) have also identified genetic factors which contribute to determining responsiveness to dietary interventions (Hsu et al, 2011; McCaffery et al, 2012; Svetkey et al, 2011). Accordingly, though extensive research remains to be conducted in this area, genetic profiling may at some point aid in the prescription of both pharmaceutical and lifestyle-based interventions for the treatment of hypertension, even in late-life.…”
Section: Future Directions – Potential Points Of Interventionmentioning
confidence: 99%
“…Субклинический метаболический дефицит витамина B 12 , критерием которого является высокое содержание в плазме крови метилмалоновой кислоты и снижение содержания в сыворотке крови уровня витамина В 12 менее 400 пкмоль/л, встречается достаточно часто, особенно у лиц пожилого возраста [24]. Согласно результатам анализа по подгруппам, в РКИ выдвинута гипотеза, что более высокие дозы витамина B 12 (напри-мер, 1 мг/сут -успешно используемая дозировка с целью профилактики развития инсульта в испытании HOPE -Heart Outcomes Prevention Evaluation 2 [25]), позволят существенно снизить содержание гомоцисте-ина и риск развития инсульта, особенно у лиц, потреб-ляющих достаточное количество фолиевой кислоты, но испытывающих дефицит витамина В 12 [24][25][26][27][28][29][30]. Эта гипотеза требует подтверждения в клинических испы-таниях.…”
Section: витамины группы вunclassified
“…[48] Several studies suggest a positive and dose-dependent association between the serum concentration of total homocysteine and the risk of stroke, which is independent of other vascular risk factors. [49] Mutations in genes of the homocysteine metabolic pathway may confer an increased risk for ischemic stroke because of elevated plasma homocysteine levels. A study carried out by Alluri et al in a South Indian population found that C677T MTHFR mutation is strongly associated with arterial stroke, especially in young adults and concluded that MTHFR allele evaluation will help in preventing/reducing morbidity caused by stroke.…”
Section: Genes Involved In Homocysteine Metabolismmentioning
confidence: 99%